Gene · 1056
Papers4,548
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,548
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer. | Theranostics | 2023 | 37771767 | PubTator, text mining | PubMed |
| Innate Immune Response to Viral Vectors in Gene Therapy. | Viruses | 2023 | 37766208 | PubTator, text mining | PubMed |
| Spheroid Formation and Recovery Using Superhydrophobic Coating for Regenerative Purposes. | Pharmaceutics | 2023 | 37765195 | PubTator, text mining | PubMed |
| Abiraterone Acetate Complexes with Biometals: Synthesis, Characterization in Solid and Solution, and the Nature of Chemical Bonding. | Pharmaceutics | 2023 | 37765151 | PubTator, text mining | PubMed |
| The Sterilization of Human Milk by Holder Pasteurization or by High Hydrostatic Pressure Processing Leads to Differential Intestinal Effects in Mice. | Nutrients | 2023 | 37764826 | PubTator, text mining | PubMed |
| Serum Cytokine and miRNA Levels Are Differently Expressed in Right- and Left-Sided Colon Cancer. | J Clin Med | 2023 | 37762927 | PubTator, text mining | PubMed |
| Circulatory miRNAs as Correlates of Elevated Intra-Pancreatic Fat Deposition in a Mixed Ethnic Female Cohort: The TOFI_Asia Study. | Int J Mol Sci | 2023 | 37762694 | PubTator, text mining | PubMed |
| Diagnostic Performance of Serum MicroRNAs for ST-Segment Elevation Myocardial Infarction in the Emergency Department. | Biomedicines | 2023 | 37760864 | PubTator, text mining | PubMed |
| Functional, Morphological and Molecular Changes Reveal the Mechanisms Associated with Age-Related Vestibular Loss. | Biomolecules | 2023 | 37759828 | PubTator, text mining | PubMed |
| Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential. | Cardiovasc Diabetol | 2023 | 37749569 | PubTator, text mining | PubMed |
| Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL. | Blood Adv | 2023 | 37748131 | PubTator, text mining | PubMed |
| Clinical Value of Circulating microRNAs in Diagnosis and Prognosis of Pancreatic Cancer: A Systematic Review. | Cureus | 2023 | 37746488 | PubTator, text mining | PubMed |
| Integrating distribution kinetics and toxicodynamics to assess repeat dose neurotoxicity in vitro using human BrainSpheres: a case study on amiodarone. | Front Pharmacol | 2023 | 37745076 | PubTator, text mining | PubMed |
| Alterations in EGFR and PDGFRA are associated with the localization of contrast-enhancing lesions in glioblastoma. | Neurooncol Adv | 2023 | 37744696 | PubTator, text mining | PubMed |
| Impact of clinico-biochemical and inflammatory biomarkers on the immunogenicity and efficacy of SARS-CoV-2 adenoviral vaccine: a longitudinal study. | J Circ Biomark | 2023 | 37744159 | PubTator, text mining | PubMed |
| METTL14-upregulated miR-6858 triggers cell apoptosis in keratinocytes of oral lichen planus through decreasing GSDMC. | Commun Biol | 2023 | 37741915 | PubTator, text mining | PubMed |
| The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment. | Front Pharmacol | 2023 | 37731742 | PubTator, text mining | PubMed |
| Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis. | Mult Scler | 2023 | 37712409 | PubTator, text mining | PubMed |
| Altered microRNA expression in patients with sarcoidosis. | Sarcoidosis Vasc Diffuse Lung Dis | 2023 | 37712378 | PubTator, text mining | PubMed |
| Insights into vitamin A in bladder cancer, lack of attention to gut microbiota? | Front Immunol | 2023 | 37711628 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1056/papers?page=16